Apimeds Pharmaceuticals US (APUS) Shares Outstanding (Diluted Average) (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) reported Shares Outstanding (Diluted Average) of $10.9 million for Q4 2025, up 37.68% on a YoY basis from $7.9 million in Q4 2024, and down 13.47% quarter-over-quarter from $12.6 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Shares Outstanding (Diluted Average) (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US has reported Shares Outstanding (Diluted Average) for 2 years, with the latest figure at $10.9 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 37.68% year-over-year to $10.9 million; the trailing twelve-month figure through Dec 2025 stood at $10.9 million (up 37.68% YoY), and the FY2025 full-year result was $10.9 million, up 37.68% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $10.9 million, down from $12.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $12.6 million in Q3 2025, with the low at $7.9 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Apimeds Pharmaceuticals US | 13.93 Mn | 10.29 Mn | - | 10.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.88 Mn |
| Sep 30, 2025 | 12.58 Mn |
| Jun 30, 2025 | 10.37 Mn |
| Mar 31, 2025 | 7.90 Mn |
| Dec 31, 2024 | 7.90 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 7.90 Mn |